Eugia Pharma gets USFDA approval

Uniindia: Hyderabad, June 7 (UNI) Aurobindo Pharma Ltd on Tuesday announced that its wholly owned subsidiary, Eugia Pharma Specialties Ltd, has received a final approval from the US Food and Drug Administration (USFDA) to manufacture and market Leuprolide Acetate Injection, 14 mg/2.8 mL MDV (Kit).

Related Keywords

Hyderabad ,Andhra Pradesh ,India ,Eugia Pharma ,Eugia Pharma Specialty Group ,Aurobindo Pharma Ltd On ,Abbvie Endocrinology Inc ,Drug Administration ,Eugia Pharma Specialties Ltd ,Aurobindo Pharma Ltd ,Leuprolide Acetate Injection ,Acetate Injection ,Multiple Dose Vials ,Lupron Injection ,Abbvie Endocrinology ,Business ,Economy ,